COLIZZI, Marco
 Distribuzione geografica
Continente #
NA - Nord America 1.056
EU - Europa 417
AS - Asia 213
AF - Africa 14
OC - Oceania 8
SA - Sud America 1
Totale 1.709
Nazione #
US - Stati Uniti d'America 1.017
IT - Italia 229
SG - Singapore 151
IE - Irlanda 94
CA - Canada 34
IN - India 26
FI - Finlandia 24
DK - Danimarca 17
DE - Germania 12
TG - Togo 11
CN - Cina 10
TR - Turchia 7
ES - Italia 6
IL - Israele 6
AT - Austria 5
AU - Australia 5
CZ - Repubblica Ceca 5
GB - Regno Unito 5
NL - Olanda 5
RS - Serbia 4
ET - Etiopia 3
FR - Francia 3
ID - Indonesia 3
JO - Giordania 3
NZ - Nuova Zelanda 3
PA - Panama 3
HK - Hong Kong 2
HU - Ungheria 2
MX - Messico 2
PH - Filippine 2
UA - Ucraina 2
AR - Argentina 1
CH - Svizzera 1
CY - Cipro 1
GR - Grecia 1
JP - Giappone 1
LK - Sri Lanka 1
NO - Norvegia 1
PL - Polonia 1
Totale 1.709
Città #
Chandler 250
Boardman 139
Singapore 119
Dublin 92
Princeton 84
Ashburn 55
Toronto 32
Andover 30
Milan 25
Rome 23
Ogden 20
Hyderabad 18
Copenhagen 16
Trieste 12
Lappeenranta 11
Lomé 11
Helsinki 10
Udine 9
Chicago 8
Istanbul 7
Santa Clara 7
Bergamo 6
Denver 6
Pune 6
Treviso 6
Dallas 5
Frankfurt am Main 5
Lonato 5
Vienna 5
Ancona 4
Brno 4
Broomfield 4
Codroipo 4
Dongguan 4
Florence 4
Tel Aviv 4
Treia 4
Vignate 4
Alcantarilla 3
Amsterdam 3
Auckland 3
Belgrade 3
Edinburgh 3
Jerash 3
Los Angeles 3
New York 3
Piacenza 3
Porcia 3
Pordenone 3
Redmond 3
San Nicola la Strada 3
Spinea 3
Surabaya 3
Sydney 3
Verona 3
Adrano 2
Ahmedabad 2
Anglès 2
Arzignano 2
Aversa 2
Baricella 2
Budapest 2
Cagliari 2
Carmona 2
Dolo 2
Faenza 2
Foggia 2
Gorizia 2
Gorle 2
Groningen 2
Hong Kong 2
Imola 2
Isola della Scala 2
Jerusalem 2
Laglio 2
Lubbock 2
Marmirolo 2
Melbourne 2
Montegiordano 2
Monterrey 2
Naples 2
Ningbo 2
Nuremberg 2
Ponte Lambro 2
Sammamish 2
San Polo di Piave 2
San Vito al Tagliamento 2
Shenzhen 2
Torre del Greco 2
Turriaco 2
Urgnano 2
Villaricca 2
West Jordan 2
Boise 1
Buenos Aires 1
Buffalo 1
Burlington 1
Cordovado 1
Cormeilles-en-Parisis 1
Dambulla 1
Totale 1.192
Nome #
Therapeutic Effect of Palmitoylethanolamide in Cognitive Decline: A Systematic Review and Preliminary Meta-Analysis of Preclinical and Clinical Evidence 109
Mental health symptoms one year after acute COVID-19 infection: prevalence and risk factors 48
The 2019 Schizophrenia International Research Society Conference, 10–14 April, Orlando, Florida: A summary of topics and trends 45
Feigning Capgras Syndrome and Developmental Prosopagnosia: a rare case of Pediatric Factitious Disorder 37
21.5 Repercussions of the First and Second COVID-19 Waves in the Italian Pediatric Population: An Inpatient Psychiatric Emergency Study 34
Cannabis use and the development of tolerance: a systematic review of human evidence 31
Using Metaphors to Understand Suffering in COVID-19 Survivors: A Two Time-Point Observational Follow-Up Study 30
4.4 IS ALTERED SENSORIMOTOR INTEGRATION A CORE FEATURE OF TOURETTE'S DISORDER? A CASE-CONTROL STUDY 30
The influence of risk factors on the onset and outcome of psychosis: What we learned from the GAP study 30
Cannabis and cognition: Connecting the dots towards the understanding of the relationship 30
Concomitant psychiatric problems and hormonal treatment induced metabolic syndrome in gender dysphoria individuals: A 2year follow-up study 30
Psychological Support, Puberty Suppression, and Psychosocial Functioning in Adolescents with Gender Dysphoria 29
Associations between psychosis endophenotypes across brain functional, structural, and cognitive domains 28
51.18 THE COVID-19 OUTBREAK IMPACT ON WELL-BEING AMONG PEOPLE WITH AUTISM SPECTRUM DISORDER IN ITALY: AN N = 527 WEB-BASED SURVEY 28
Is the Adolescent Brain at Greater Vulnerability to the Effects of Cannabis? A Narrative Review of the Evidence 28
Childhood trauma and being at-risk for psychosis are associated with higher peripheral endocannabinoids 28
The Autism–Psychosis Continuum Conundrum: Exploring the Role of the Endocannabinoid System 28
Cannabis users are less sensitive to the acute psychotomimetic effects of delta-9-tetrahydrocannabinol administration 27
Adolescent lifestyle behaviors, coping strategies and subjective wellbeing during the covid-19 pandemic: An online student survey 26
Attachment styles in transsexual patients and clinical and nonclinical control groups: A Response 25
Additional evidence for neuropsychiatric manifestations in mosaic trisomy 20: A case report and brief review 25
The collaborative outcomes study on health and functioning during infection times in adults (COH-FIT-Adults): Design and methods of an international online survey targeting physical and mental health effects of the COVID-19 pandemic 25
Cannabis: Neuropsychiatry and its effects on brain and behavior 25
Prevention in Mental Health: From Risk Management to Early Intervention 24
Confirmation of increased and more severe adolescent mental health-related in-patient admissions in the COVID-19 pandemic aftermath: A 2-year follow-up study 24
Hyperprolactinaemia in first episode psychosis - A longitudinal assessment 24
Effect of cannabis on glutamate signalling in the brain: A systematic review of human and animal evidence 24
Poster #35 STUDYING EPISODIC MEMORY CEREBRAL NETWORK: A NOVEL EVENT-RELATED TASK FOR FMRI 24
Is It Time to Test the Antiseizure Potential of Palmitoylethanolamide in Human Studies? A Systematic Review of Preclinical Evidence 24
Association of cannabis with glutamatergic levels in patients with early psychosis: Evidence for altered volume striatal glutamate relationships in patients with a history of cannabis use in early psychosis 24
COGNITIVE DEFICITS AS INTERMEDIATE PHENOTYPE IN SCHIZOPHRENIA 24
Mentalization in young patients undergoing opioid agonist treatment: Implications for clinical management 23
Cannabis Use in Autism: Reasons for Concern about Risk for Psychosis 23
Cannabis and psychosis: What do we know and what should we do? 23
Postural control in childhood: Investigating the neurodevelopmental gradient hypothesis 23
Investigating gait, movement, and coordination in children with neurodevelopmental disorders: Is there a role for motor abnormalities in atypical neurodevelopment? 22
Further evidence on the interplay between benzodiazepine and Z-drug abuse and emotion dysregulation 22
The Supplementation Therapy in Autism and Response to Treatment (START) Study: An Open-Label Feasibility Trial of Ultramicronized Palmitoylethanolamide Potential to Alleviate Psychic Distress among Autistic Adults 21
Differential gene expression analysis in blood of first episode psychosis patients 21
COVID-19-induced neuropsychiatric symptoms can persist long after acute infection: a 2-year prospective study of biobehavioral risk factors and psychometric outcomes 20
O3.4. DOES CANNABIS INDUCE PSYCHOSIS BY ALTERING GLUTAMATE SIGNALING IN THE STRIATUM? 19
Jumping to conclusions at first onset of psychosis predicts longer admissions, more compulsory admissions and police involvement over the next 4 years: the GAP study 19
Palmitoylethanolamide and its biobehavioral correlates in autism spectrum disorder: A systematic review of human and animal evidence 19
Effects of short-term cannabidiol treatment on response to social stress in subjects at clinical high risk of developing psychosis 18
Lo stigma nella salute mentale 18
The effect of cross-sex hormonal treatment on gender dysphoria individuals’ mental health: A systematic review 18
Transsexual patients' psychiatric comorbidity and positive effect of cross-sex hormonal treatment on mental health: Results from a longitudinal study 17
Poster #103 INTERACTION BETWEEN COMT GENOTYPE, CANNABIS USE, AND BFQ MEASURES OF SOCIABILITY 17
Delta-9-tetrahydrocannabinol increases striatal glutamate levels in healthy individuals: implications for psychosis 17
Poster #M195 THE INTERACTION BETWEEN CNR1 GENETIC VARIATION AND CANNABIS EXPOSURE PREDICTS PREFRONTAL FUNCTIONAL CONNECTIVITY AND BEHAVIOR DURING WORKING MEMORY 16
Unraveling the Intoxicating and Therapeutic Effects of Cannabis Ingredients on Psychosis and Cognition 16
Biobehavioral Interactions between Endocannabinoid and Hypothalamic-pituitary-adrenal Systems in Psychosis: A Systematic Review 15
COVID-19 Survivors Are Still in Need of Neuropsychiatric Support Two Years after Infection 14
Is there sufficient evidence that cannabis use is a risk factor for psychosis? 14
Epigenetic Regulation and Genetic Variation of AKT1 Predict Prefrontal Physiology 14
Epigenetic mediation of akt1 rs1130233′s effect on delta-9-tetrahydrocannabinol-induced medial temporal function during fear processing 14
Sociodemographic and clinical changes in pediatric in-patient admissions for mental health emergencies during the COVID-19 pandemic: March 2020 to June 2021 14
Risk of psychosis in autism spectrum disorder individuals exposed to psychosocial stressors: A 9-year chart review study 13
Where Do Neurodevelopmental Disorders Go? Casting the Eye Away from Childhood towards Adulthood 13
Editorial: Case reports in autism 13
Should we be concerned about stigma and discrimination in people at risk for psychosis? A systematic review 13
Do cannabis users develop tolerance for the psychoactive effects of delta-9-tetrahydrocannabinol? An fMRI study 13
A prediction modelling and pattern detection approach for the first-episode psychosis associated to cannabis use 13
Medically unexplained symptoms in the times of COVID-19 pandemic: A case-report 13
Prevalence and risk factors for depression in factitious disorder: a systematic review 12
Introduction 12
Prenatal insomnia disorder may predict concurrent and postpartum psychopathology: A longitudinal study 12
Vortioxetine Add-On to Methylphenidate for the Treatment of Symptoms of Sickness Behavior in Attention-Deficit Hyperactivity Disorder: Report of Two Cases 12
F68. PREMORBID IQ, EDUCATIONAL LEVEL AND JUMPING TO CONCLUSIONS AS PREDICTORS OF CLINICAL OUTCOME AT FIRST ONSET OF PSYCHOSIS OVER THE NEXT 4 YEARS: THE GAP STUDY 12
Interaction between DRD2 and AKT1 genetic variations on risk of psychosis in cannabis users: A case-control study 12
Evaluating psychobiological and mental distress in transsexualism before and after cross-sex hormonal treatment: Lesson learned from three longitudinal studies 12
Interaction between childhood adversity and functional polymorphisms in the dopamine pathway on first-episode psychosis 12
Previous cannabis exposure modulates the acute effects of delta-9-tetrahydrocannabinol on attentional salience and fear processing 12
Stigma as the main obstacle in health care and human rights among people with mental disorders. A rights-based ethics approach 12
Editorial: The Endocannabinoid System: Filling the Translational Gap Between Neuroscience and Psychiatry 12
Gender-Oriented Mental Health Prevention: A Reappraisal 12
S224. DELTA-9-TETRAHYDROCANNABINOL CHALLENGE IN CANNABIS USERS AND NON-USERS DIFFERENTIALLY AFFECTS BRAIN FUNCTION AND BEHAVIOR: AN FMRI STUDY OF DEVELOPMENT OF TOLERANCE 12
Validation of the Collaborative Outcomes study on Health and Functioning during Infection Times (COH-FIT) questionnaire for adults 11
Pediatric emergency department mental health assessments in the 2 years following the COVID-19 outbreak reveal higher vulnerability for eating disorder and suicide risk 11
To treat or not to treat: Puberty suppression in childhood-onset gender dysphoria 11
Effects of continuation, frequency, and type of cannabis use on relapse in the first 2 years after onset of psychosis: an observational study 11
The Neural Substrate of Reward Anticipation in Health: A Meta-Analysis of fMRI Findings in the Monetary Incentive Delay Task 11
Does Cannabis Composition Matter? Differential Effects of Delta-9-tetrahydrocannabinol and Cannabidiol on Human Cognition 11
Normalization of mediotemporal and prefrontal activity, and mediotemporal-striatal connectivity, may underlie antipsychotic effects of cannabidiol in psychosis 11
S152. CANNABIDIOL INDUCED MODULATION OF MEDIOTEMPORAL ACTIVITY DURING A VERBAL MEMORY TASK IN FIRST-EPISODE PSYCHOSIS 11
Meet the Editorial Board Member 11
Lessons learnt while designing and conducting a longitudinal study from the first Italian COVID-19 pandemic wave up to 3 years 10
Association between stressful life events and psychosis relapse: a 2-year prospective study in first-episode psychosis 10
Lessons Learnt From Running a Transition-Age Youth Mental Health Outpatient Clinic in Italy: The PRecocity of Intervention in Adolescent Medicine (PRIMA) Experience 10
Editorial: Methods and applications in addiction psychiatry research: 2021 10
Psychosocial and behavioral impact of COVID-19 in autism spectrum disorder: An online parent survey 10
Neurocognitive effects of cannabis: Lessons learned from human experimental studies 10
Interaction between functional genetic variation of DRD2 and cannabis use on risk of psychosis 10
Prefrontal activity during working memory is modulated by the interaction of variation in CB1 and COX2 coding genes and correlates with frequency of cannabis use 10
Dissociative symptoms in individuals with gender dysphoria: Is the elevated prevalence real? 10
Longitudinal assessment of the effect of cannabis use on hospital readmission rates in early psychosis: A 6-year follow-up in an inpatient cohort 10
Prevention and early intervention in youth mental health: Is it time for a multidisciplinary and trans-diagnostic model for care? 10
Effectiveness of equine-assisted activities and therapies for improving adaptive behavior and motor function in autism spectrum disorder 10
Differential sensitivity to the acute psychotomimetic effects of delta-9-tetrahydrocannabinol associated with its differential acute effects on glial function and cortisol 10
Tic-Related Obsessive-Compulsive and Eating Disorders in Dandy-Walker Variant: A Case Report and Systematic Reappraisal of Psychiatric Profiles 10
Totale 1.931
Categoria #
all - tutte 21.848
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.848


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022463 0 0 0 0 0 0 92 175 0 0 41 155
2022/2023745 87 13 27 88 63 177 34 56 93 35 43 29
2023/2024458 47 40 14 12 29 20 37 91 42 44 41 41
2024/2025401 106 151 144 0 0 0 0 0 0 0 0 0
Totale 2.067